Octapeptin Supplementation Alleviates Clostridium perfringens-Induced Growth Depression and Intestinal Inflammation in Broiler Chickens, with Effects Comparable to Enramycin

This study evaluated dietary octapeptin as an alternative to enramycin for alleviating Clostridium perfringens-associated damage in broilers. A total of 240 one-day-old Lingnan Yellow broilers were assigned to four groups with six replicates of 10 birds: an unchallenged control, a challenged control, and challenged groups receiving enramycin (10 mg/kg) or octapeptin (40 mg/kg). The trial lasted 21 days. Clostridium perfringens challenge successfully induced necrotic enteritis: compared with the unchallenged control, the challenged control showed lower final body weight, and higher intestinal lesion scores. Compared with the challenged control, both additives increased final body weight and reduced serum alanine aminotransferase, lactate dehydrogenase, interferon-γ, and interleukin-6 (p < 0.05). Octapeptin additionally reduced serum alkaline phosphatase and increased high-density lipoprotein cholesterol (p < 0.05). Both additives reduced jejunal NLRP3, CASP1, MyD88, and NF-κB expression and ileal CASP1 expression, while octapeptin also reduced jejunal TLR2 and ileal TLR2 and TGF-β1 expression (p < 0.05). Moreover, octapeptin alleviated jejunal villus atrophy, as indicated by greater villus height and a higher villus height-to-crypt depth ratio, and restored jejunal occludin expression (p < 0.05), indicating preserved mucosal architecture and barrier integrity. Serum interleukin-1β remained elevated despite supplementation. These findings support octapeptin as a potential alternative to enramycin for alleviating growth depression and intestinal injury, with benefits associated with improved serum biochemical indicators and reduced inflammatory responses.

Authors

Institutions

Publication Details

Journal
Animals
Published
2026-11-17
DOI
https://doi.org/10.3390/ani16223645
Primary Topic
Animal Nutrition and Physiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Octapeptin Supplementation Alleviates Clostridium perfringens-Induced Growth Depression and Intestinal Inflammation in Broiler Chickens, with Effects Comparable to Enramycin

Yueyang Xie, 修良 丁, Shiyan Qiao, Li Wang et al.
1 links
Animals
Animal Nutrition and Physiology
article

Octapeptin Supplementation Alleviates Clostridium perfringens-Induced Growth Depression and Intestinal Inflammation in Broiler Chickens, with Effects Comparable to Enramycin

Yueyang Xie, 修良 丁, Shiyan Qiao, Li Wang, Xianfu Meng, Feiyun Yang, Jiang Zhang, Ruiyu Diao
article en

Abstract

This study evaluated dietary octapeptin as an alternative to enramycin for alleviating Clostridium perfringens-associated damage in broilers. A total of 240 one-day-old Lingnan Yellow broilers were assigned to four groups with six replicates of 10 birds: an unchallenged control, a challenged control, and challenged groups receiving enramycin (10 mg/kg) or octapeptin (40 mg/kg). The trial lasted 21 days. Clostridium perfringens challenge successfully induced necrotic enteritis: compared with the unchallenged control, the challenged control showed lower final body weight, and higher intestinal lesion scores. Compared with the challenged control, both additives increased final body weight and reduced serum alanine aminotransferase, lactate dehydrogenase, interferon-γ, and interleukin-6 (p < 0.05). Octapeptin additionally reduced serum alkaline phosphatase and increased high-density lipoprotein cholesterol (p < 0.05). Both additives reduced jejunal NLRP3, CASP1, MyD88, and NF-κB expression and ileal CASP1 expression, while octapeptin also reduced jejunal TLR2 and ileal TLR2 and TGF-β1 expression (p < 0.05). Moreover, octapeptin alleviated jejunal villus atrophy, as indicated by greater villus height and a higher villus height-to-crypt depth ratio, and restored jejunal occludin expression (p < 0.05), indicating preserved mucosal architecture and barrier integrity. Serum interleukin-1β remained elevated despite supplementation. These findings support octapeptin as a potential alternative to enramycin for alleviating growth depression and intestinal injury, with benefits associated with improved serum biochemical indicators and reduced inflammatory responses.

AnimalsVol. 16(22)
Chongqing Academy of Animal Science (CN)
National Key Research and Development Program of China
Zero hunger, Good health and well-being
Animal Nutrition and Physiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon